TNFRSF13C Gene Immunodeficiency common variable type 4 Genetic Test
At DNA Labs UAE, we offer the TNFRSF13C Gene Immunodeficiency common variable type 4 Genetic Test. This test is used to diagnose a type of primary immunodeficiency disorder caused by mutations in the TNFRSF13C gene.
Test Components and Price
- Components: TNFRSF13C Gene Immunodeficiency common variable type 4 Genetic Test
- Price: 4400.0 AED
Sample Condition and Report Delivery
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Method and Test Type
- Method: NGS Technology (Next-Generation Sequencing)
- Test Type: Osteology Dermatology Immunology Disorders
Doctor and Test Department
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Before undergoing the TNFRSF13C Gene Immunodeficiency common variable type 4 Genetic Test, it is important to provide the clinical history of the patient. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with TNFRSF13C Gene Immunodeficiency common variable type 4 NGS Genetic DNA Test gene TNFRSF13C.
Test Details
TNFRSF13C gene immunodeficiency common variable type 4 is a type of primary immunodeficiency disorder caused by mutations in the TNFRSF13C gene. This gene is responsible for producing a protein called BAFF receptor, which plays a role in the development and survival of certain immune cells.
NGS genetic testing, using advanced sequencing technology, can analyze multiple genes simultaneously. In the case of TNFRSF13C gene immunodeficiency common variable type 4, NGS genetic testing can identify mutations in the TNFRSF13C gene that may be responsible for the disorder.
NGS genetic testing is useful for diagnosing TNFRSF13C gene immunodeficiency common variable type 4 by detecting mutations in the TNFRSF13C gene. It can also be used for carrier testing in individuals with a family history of the disorder and for prenatal testing in families with a known mutation.
The results of NGS genetic testing provide important information for the management and treatment of individuals with TNFRSF13C gene immunodeficiency common variable type 4. It helps in determining appropriate treatment strategies and identifying other family members who may be at risk for the disorder.
| Test Name | TNFRSF13C Gene Immunodeficiency common variable type 4 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TNFRSF13C Gene Immunodeficiency common variable type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNFRSF13C Gene Immunodeficiency common variable type 4 NGS Genetic DNA Test gene TNFRSF13C |
| Test Details |
TNFRSF13C gene immunodeficiency common variable type 4 is a type of primary immunodeficiency disorder caused by mutations in the TNFRSF13C gene. This gene provides instructions for producing a protein called BAFF receptor, which is involved in the development and survival of certain immune cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of TNFRSF13C gene immunodeficiency common variable type 4, NGS genetic testing can be used to identify mutations in the TNFRSF13C gene that may be responsible for the disorder. NGS genetic testing can help in the diagnosis of TNFRSF13C gene immunodeficiency common variable type 4 by detecting mutations in the TNFRSF13C gene that may be causing the disorder. It can also be used for carrier testing in individuals with a family history of the disorder, as well as for prenatal testing in families with a known mutation. The results of NGS genetic testing can provide important information for the management and treatment of individuals with TNFRSF13C gene immunodeficiency common variable type 4. It can help in determining the appropriate treatment strategies and in identifying other family members who may be at risk for the disorder. |
